Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test may predict infection danger for blood cancer patients

NCT ID NCT05844033

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 33 times

Summary

This study looks for a blood test that can tell which patients with chronic lymphocytic leukemia (CLL) or multiple myeloma are at higher risk for infections. Researchers will use advanced lab methods to analyze blood samples from 150 adults. The goal is to help doctors prevent infections before they happen.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, 02215, United States

Conditions

Explore the condition pages connected to this study.